CTXR vs DRI · $13.4M cap vs P/E 22, rev $13.21B
Citius Pharmaceuticals Inc (CTXR) versus Darden Restaurants Inc (DRI) — a side-by-side from cached financials, not a winner call.
Citius Pharmaceuticals Inc (CTXR) is a biotechnology company listed on US.
Darden Restaurants Inc (DRI) is a restaurants company listed on NYSE.
CTXR does not have a complete income-statement cache yet.
Latest reported DRI revenue for 2026-05-31 was $13.21B. Net income was $1.21B. Revenue was up 9.4% from 2025-05-25 to 2026-05-31. DRI currently screens at market cap $24.20B and trailing P/E 22.3.
CTXR currently screens at market cap $13.4M. DRI currently screens at market cap $24.20B and trailing P/E 22.3.
Not investment advice. Open the CTXR and DRI stock pages for the full models.
Not investment advice.